Portada | Volúmenes anteriores

Ginecología y Obstetricia
© Sociedad Peruana de Obstetricia y Ginecología
 



Ginecol. obstet.  2003; 49 (4) : 242


SATISFACCIÓN DE LAS USUARIAS DE IMPLANTES DE LEVONORGESTREL. 
EXPERIENCIA DEL HOSPITAL NACIONAL CAYETANO HEREDIA

Juan Pretell, Juan Mauricio.


 

BIBLIOGRAFÍA

  1. Hatcher R, Rinehart W, Blackburn R. Lo esencial de la tecnología anticonceptiva. Facultad de Salud Pública. Universidad de John Hopkins. 1999.

  2. Coukell AJ, Balfour JA. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability. Drugs 1998; 55: 861-17.

  3. Kirkman RJ, Bromham DR, O'Connor TP, Sahota JE. Prospecti ve multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results: Br J Fam Plann 1999; 25(2): 36-40.

  4. Wyeth Laboratories Inc. Norplantâ system (Levonorgestrel iniplants): prescribing information. Philadelphia, PA, USA. 23 Jul 1996.

  5. World Health Organization. Improving access to quality care in family planning: medical eligibility criteria for contraceptive use. World Health Organization WH0/FRH/FPP/96.9.Geneva.1996.

  6. Berek J, Adashi E, Hillard P. Ginecología de Novak. Mc Graw Hill.1999.

  7. Tseng L-H, Lee T-Y, Yang Y-S, et al. Norplant subdermal contraceptive systern: experience in Taiwan. Contraception 1996; 53: 177-80.

  8. Singh K, Viegas OAC, Fong YF, et al. Acceptability of Norplantâ implants for fertility regulation in Singapore. Contraception 1992; 45: 39-47.

  9. Buckshee K, Chatterjee P, Dhall Gi, et al. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR task Force on Hormonal Contraception. Contraception 1995; 51: 237-42.

  10. Brache V, Faundes A, Johansson E, et al. Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplantâ implants. Contraception 1995; 31 (3): 261-73.

  11. Brache V, Alvarez-Sánchez F, Faundes A, et al. Ovarian endocrine function through five years continuous treatment with Norplantâ subdermal contraceptive implants. Contraception 1990; 41: 169-77.

  12. Faundes A, Cochon L, Brache V, et al. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants. Fertil Steril 1991; 56: 27-31.

  13. Shaaban MM, Ghaneimah SA, Segal S, et al. Sonographic assessment of ovarian and endometrial changes during long-term Norplantâ use and their correlation with hormonal levels. Fertil Steril 1993; 59: 998-1002.

  14. Croxatto HB, Diaz S, Salvatierra AM, et al. Treatment of Norplantâ subdemal implants inhibits sperm penetration through cervical mucus in vitro. Contraception 1987; 36 (2): 193-201.

  15. Mosby's Complete Drug reference 7th edition. Levonorgestrel. St. Louis: Mosby. 1997.

  16. Eilers GM, Swanson TK. Women's satisfaction with Norplantlâ, as compared with oral contraceptives. J Fam Pract 1994; 38 (6): 596600.

  17. Ruminjo JK, Amatya RN, Dunson TR, Krueger SL, Chi-I. Norplantâ, implants acceptability and user satisfaction among women in two African countries. Contraception 1996; 53(2): 101-7.

  18. Noerpramana NP. A cohort study of Norplantâ implant: Side-effects and acceptance-Adv Contracept 1995; 11 (2): 97-114.

  19. Sihvo S, Ollila E, Hemminki E. Perceptions and satisfaction among Norplantâ users in Finland. Acta Obstet Gynecol Scand 1995; 74(6): 441-5.

  20. Rehan N, lmayatullah A, Chaudhary I. Norplantâ: User's perspective in Pakistan. Adv Contracept 1999; 15(2): 95-107.

  21. Clarke LL, Schmitt K, Bono CA, Steele J, Miller MK. Norplantlâ, selection oral satisfaction among low-income women. Am J Public Health 1998; 88(8): 1175-81.

  22. Argina H, Lukman HY. Norplantâ implants in Ethiopia. East Afr Med J 1997; 74 (4): 258-62.

  23. Haugen MM, Evans CB, Kin MH. Patient satisfaction with levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal. J Reprod Med 1996; 41 (11): 849-54.

  24. Llanos-Zavalaga F, Rosas-Aguirre A, Mendoza Reguera D, Contreras Ríos C. Comparación de las escalas de Likert y vigesimal para la evaluación de satisfacción de atención en un hospital del Perú. Rev Med Herediana 2001; 12 (2): 52-7.

  25. Balarezo GN. Características y experiencia en el uso de las aceptantes del rnétodo anticonceptivo Norplantâ en Lima, Perú. Tesis para optar el grado de maestro en Salud Pública con mención en Salud y Población. Lima-U.P.C.H., 1992.

  26. Mauricio PJ, Núñez PJ, Maradiegue ME. Experiencia con el implante de levonorgestrel en el Hospital Nacional Cayetano Heredia. Ginecol Obstet (Perú) 1995; 41 (1).

  27. Fraser IS, Tiitinen A, Affandi B, et al. Norplantâ consensus statement and background review. Contraception 1998; 57: 1-9.

  28. Ortayli N. User's perspective on implantable contraception for women. Contraception 2002; 65 (1): 107-11.

  29. Glantz S, Glantz JC, Campbell-Heider N, Schaff E. Norplantâ use among urban minority women in the United States. Contraception 2000; 61 (2): 83-90.

  30. Choompootaweep S, Kochagarn E, Sirisumpan S, et al. Effectiveness of Norplantâ implants among Thai Women in Bangkok. Contraception 1996; 53 (1): 33-6.

  31. 31. Ba MG, Moreau JC, Sokal D, Dunson R, Dao B, Kovedow D, Diadhiou F. A5-year clinical evaluation of Norplantâ implants in Senegal. Contraception 1999; 59(6): 377-81.

  32. Chetri M, Bhatta A, Amatya RN, et al. Five-year evaluation of safety, efficacy and acceptability of Norplantâ implants in Nepal. Adv Contracept 1996; 12 (9): 187-99.

  33. Shoupe D, Mishell DR Jr, Bopp BL, et al. The significance of bleeding patterns in Norplantâ implant user's. Obstet Gynecol 1001; 77(2): 256-60.

 

 

Texto completo | Tabla de contenido

   

Volúmenes anteriores | Listado por Títulos


UNMSM | Sistema de Bibliotecas | Biblioteca Digital

© 1997-2008 UNMSM. Oficina General del Sistema de Bibliotecas y Biblioteca Central
Comentarios y/o sugerencia : sisbiblio@unmsm.edu.pe
Todos los derechos reservados
Lima - Perú